‘Seminal’ Allergan Cases Test Copycat Drug Limits

Law360, New York (November 27, 2017, 11:08 PM EST) — Two recently filed lawsuits from Allergan PLC are teeing up a pivotal test of the extent to which drug compounders can mass-produce virtual copies of brand-name prescription drugs, attorneys say.
Continue reading the story on Law360.